Shanghai drugmaker Hua hauls in $117M megaround, with plans for hefty Hong Kong IPO
A diabetes drugmaker recently rumored to be planning a massive Hong Kong IPO has raised a $117 million mega-round with backing from some of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
